Alzamend Neuro, Inc.
SEC CIK 1677077 · ALZN · last insider filing 2026-04-16
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Ault Milton C III | Director | filed 2021 - 2026 |
| Horne William B. | Director | filed 2021 - 2025 |
| Mcgrath Lynne Fahey | Director | filed 2021 - 2025 |
| Jackman Stephan | Director · Chief Executive Officer | filed 2021 - 2023 |
| Gustafson Mark | Director | filed 2021 - 2022 |
| Oram Jeffrey | Director | filed 2021 - 2022 |
| Woo Andrew H. | Director | filed 2021 - 2022 |
| Nisser Henry Carl | Director · Exec VP and General Counsel | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Katzoff David J | Chief Operating Officer | filed 2021 - 2025 |
| Cragun Kenneth S | SVP of Finance | filed 2021 - 2022 |
| Lien Escalona | Chief Financial Officer | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.